Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of ...

Fintel reports that on November 11, 2025, Wells Fargo maintained coverage of Keros Therapeutics (NasdaqGM:KROS) with a ...

Detailed price information for Keros Therapeutics Inc (KROS-Q) from The Globe and Mail including charting and trades.

Keros Therapeutics, Inc. ( NASDAQ:KROS ) defied analyst predictions to release its quarterly results, which were ...

Detailed price information for Keros Therapeutics Inc (KROS-Q) from The Globe and Mail including charting and trades.

Fintel reports that on November 6, 2025, Wedbush maintained coverage of Keros Therapeutics (NasdaqGM:KROS) with a Neutral ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...

Evening lights glow early at Dixie Diner, creating a mellow atmosphere for locals grabbing dinner, pie, or a late coffee. The ...

Additionally, Keros Therapeutics reported positive clinical data for its DMD drug candidate, KER-065, from a Phase 1 trial presented at a recent conference. The U.S. Food and Drug Administration has ...

Additionally, Keros reported positive data from its Phase 1 trial of KER-065, a treatment candidate for Duchenne muscular dystrophy (DMD), at a recent medical conference. In a regulatory development, ...

The Guadeloupean action film Zion by Nelson Foix, starring Sloan Decombes, will be broadcast on Canal+ on November 15, 2025, ...